<DOC>
	<DOCNO>NCT00001121</DOCNO>
	<brief_summary>The purpose study evaluate long-term consequence HIV-1 infection occur association know , discourage , high-risk behavior person receive HIV candidate vaccine placebo HIVNET 014 . Doctors need look patient respond HIV infection order develop new HIV vaccine treatment HIV AIDS . Patients receive HIV vaccine sometimes protect HIV infection . More often , patient become HIV-positive experience boost immune system help body fight HIV . Doctors need look patient respond HIV infection order develop new HIV vaccine treatment HIV AIDS .</brief_summary>
	<brief_title>A Study Monitor Health Participants HIVNET 014 Who Become Infected With HIV-1</brief_title>
	<detailed_description>There many possible outcome HIV-1 infection among person receive experimental HIV-1 vaccine . In best-case scenario , vaccine may prevent infection ( sterilize immunity ) . However , current viral vaccine think limit , prevent , virus replication infection . In latter case , important document effect immune response disease course reflect viral load , evolution viral quasi specie , clinical symptom time . Understanding evolution immune response vaccinee subsequent exposure HIV infection potentially result valuable information subsequent design preventive therapeutic vaccine . This study use HIVNET 014 participant high risk HIV-1 infection . Participants discontinue HIVNET 014 vaccination upon confirmation HIV-1 infection enrol study . Participants undergo clinical laboratory examination every 3 month first year follow-up every 6 month least 4 year thereafter . Additionally , HIV-infected partner HIVNET 014A participant undergo clinical laboratory examination enrollment , may ask donate additional specimen later time . Study endpoint include various virologic , immunologic , clinical parameter , viral load , cellular immune response , virus phenotype genotype .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Become infect HIV participate HIVNET 014 , HIVpositive partner ( sexual needlesharing ) HIVNET 014A participant . Are able willing provide write informed consent . Exclusion Criteria Patients eligible study : Have serious psychiatric psychological disorder would prevent complete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2003</verification_date>
	<keyword>Placebos</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>Follow-Up Studies</keyword>
	<keyword>HIV Therapeutic Vaccine</keyword>
</DOC>